Day-care Versus Overnight-stay Laparoscopic Cholecystectomy Randomized Controlled Trial. (DOLCE)

• Evidence of better quality of life revealed by SF-36 test [ Time Frame: before surgery, 7 days after surgery, 30 days after surgery ]
  

• Readmissions, Postoperative pain, Wound infections, Intraoperative and postoperative complications, Duration of operation(minutes), Return to normal activity (days) defined as time until return to full activity, work, school or sport. [ Time Frame: prior to surgery, 7 days after surgery and 30 days after surgery ]
  

The DOLCE study project is a prospective, randomised, open label, comparison of LC performed either as a day-care procedure or with overnight stay with symptomatic gallstones.

The aim of this study was to evaluate the feasibility, safety and patient acceptance of outpatient LC in Italy. In particular this randomized clinical trial will use the SF-36 as powerful instrument to compare quality of life and global health status after LC performed as a day-care procedure or with an overnight stay.

The outcome measured are the following:

1. quality of life and health status
2. admissions and readmissions;
3. postoperative pain (SVS, number of analgesic doses);
4. wound infections (rate);
5. intraoperative and postoperative complications
6. duration of operation (minutes), defined as operating time, anesthesia time, or operating room time;
7. return to normal activity (days), subdivided in: time until return to full activity, work, or sport; The instrument used to assess quality of life and heath status will be SF-36. The study will be performed in a Day-Surgery Unit where an over-night stay is possible in case of complications.

INCLUSION AND EXCLUSION CRITERIA

Inclusion criteria are:

• Adult (from 18 to 70 years old) patients presenting for gallstone disease surgery (symptomatic cholelithiasis, according to the Rome criteria ) confirmed by ultrasound living less than 50 km from the hospital (the day-care protocol specifies that an adult must be available to accompany the patient home and stay there overnight) were considered for entry into the trial.

Exclusion criteria

• Refusing of informed consent
• Any condition preventing a correct evaluation of pain (non-cooperative patient, blind patient)
• Patients with contraindication to be operated with LC
• Patients with an American Society of Anesthesiologists (ASA) score of III or more.
• BMI >35 kg/m2
• Asthma
• extensive previous abdominal surgery
• patients with a clinical suspicion of common bile duct stones or a history of acute cholecystitis or pancreatitis, calcified gallbladder.